Products
Online Inquiry
Ralimetinib dimesylate
Inquiry
Cat. No.:
OB0125LY-095
Size:
1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg
CAS No.:
862507-23-1
Compound CID:
11570805
Specification
Description:
Ralimetinib dimesylate is a small molecule compound that belongs to the MAPK inhibitor and works mainly by inhibiting specific signaling pathways.
Formula Weight:
612.74
Stability:
3 years in powder form.
Applications:
Ralimetinib dimesylate has strong anti-tumor activity and can be used in studies of non-small cell lung cancer and other solid tumor diseases.
Storage:
Storage at -20°C.
Formula:
C24H29FN6·2CH4O3S
Appearance:
Solid
Purity:
99.3%
Identity:
Confirmed by NMR and HPLC.
Targets&IC50:
p38α: 7 nM
Library Information
Plate Number:
AOCL-5
Plate Location:
b2
Empty Location:
a1-h1; a12-h12
Formulation:
10mM DMSO
Container:
96-well plate
Pathways:
Autophagy; Apoptosis; MAPK
Targets:
Autophagy; p38 MAPK; Apoptosis
Receptors:
Apoptosis; Autophagy; p38 MAPK; p38α
DMSO Max Solubility (mg/mL):
27.5 mg/mL
DMSO Max Solubility (mM):
44.88 mM
ALogP:
5.117
HBA_Count:
3
HBD_Count:
2
Rotatable Bond:
5